Company: ICUI
Filing Date: 2025-08-07
Form Type: 10-Q
Source: 0000883984-25-000030
Chunk: 147

Company: ICU MEDICAL INC/DE
Filing Date: 2025-08-07
Form: 10-Q
Item: Item 8
Chunk 147
---
$(8,978)$1,819 $(32,642)

33

ICU MEDICAL, INC. AND SUBSIDIARIESNOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)

Foreign Currency Translation AdjustmentsUnrealized Gains (Losses) on Cash Flow HedgesOther AdjustmentsTotalBalance as of January 1, 2024$(76,784)$21,884 $1,819 $(53,081)Other comprehensive (loss) income beforereclassifications(22,817)13,908 — (8,909)Amounts reclassified from AOCI— (7,548)— (7,548)Other comprehensive (loss) income(22,817)6,360 — (16,457)Balance as of March 31, 2024$(99,601)$28,244 $1,819 $(69,538)Other comprehensive (loss) income before reclassifications(15,865)436 — (15,429)Amounts reclassified from AOCI— (6,818)— (6,818)Other comprehensive loss(15,865)(6,382)— (22,247)Balance as of June 30, 2024$(115,466)$21,862 $1,819 $(91,785)

Note 20:  Commitments and Contingencies

Legal ProceedingsFrom time to time, we are involved in various legal proceedings, most of which are routine litigation, in the normal course of business. Our management does not believe that the resolution of the unsettled legal proceedings that we are involved with will have a material adverse impact on our financial position or results of operations.Off-Balance Sheet Arrangements     In the normal course of business, we have agreed to indemnify our officers and directors to the maximum extent permitted under Delaware law and to indemnify customers as to certain intellectual property matters or other matters related to sales of our products. There is no maximum limit on the indemnification that may be required under these agreements. Although we can provide no assurances, we have never incurred, nor do we expect to incur, any material liability for indemnification.ContingenciesPrior to being acquired, during 2021, Smiths Medical received a Warning Letter from the U.S. Food and Drug Administration ("FDA") following an inspection of Smiths Medical’s Oakdale, Minnesota Facility (the "